Showing results (121-130 of 250) with videos related to

Sort By:
Pageof 25
Endocrine-Related Cancer|May 30, 2008
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)Naomi E Allen, Timothy J Key, Laure Dossus, et al.
International Journal of Cancer|January 23, 2015
Association of breast cancer risk loci with breast cancer survivalMyrto Barrdahl, Federico Canzian, Sara Lindström, et al.
BMC Medicine|April 30, 2021
Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and NutritionNathalie Kliemann, Vivian Viallon, Neil Murphy, et al.
BMC Medicine|January 11, 2022
Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysisEmmanouil Bouras, Ville Karhunen, Dipender Gill, et al.
Plos One|July 4, 2008
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3)Alpa V Patel, Iona Cheng, Federico Canzian, et al.
Breast Cancer Research : BCR|April 19, 2015
Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control studyKaja Tikk, Disorn Sookthai, Renée T Fortner, et al.
BMC Medicine|February 9, 2017
Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohortRenée T Fortner, Danja Sarink, Helena Schock, et al.
Gynecologic Oncology|June 8, 2021
Prospective analysis of circulating metabolites and endometrial cancer riskLaure Dossus, Eirini Kouloura, Carine Biessy, et al.
International Journal of Cancer|March 31, 2006
Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)Martijn Verheus, Petra H M Peeters, Sabina Rinaldi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 5, 2011
Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control studyRebecca E James, Annekatrin Lukanova, Laure Dossus, et al.
Pageof 25